ClinicalTrials.Veeva

Menu

Permissive Intrapartum Glucose Control

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Pregestational Diabetes
Gestational Diabetes

Treatments

Procedure: Permissive intrapartum glucose control
Procedure: Usual Care

Study type

Interventional

Funder types

Other

Identifiers

NCT05553275
HSC-MS-22-0577

Details and patient eligibility

About

The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.

Enrollment

96 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Singleton gestation
  • Presenting for intrapartum management (induction, labor, augmentation)
  • Any diagnosis of Type 1 Diabetes Mellitus(T1DM), Type 2 Diabetes Mellitus (T2DM), or Gestational Diabetes
  • English or Spanish fluency

Exclusion criteria

  • Major fetal anomalies affecting glucose metabolism
  • Multiple Gestation
  • Incarcerated subjects
  • less than 34 weeks gestation of pregnancy
  • Planned cesarean delivery
  • Utilizing insulin pump during labor
  • Stillbirth
  • Presenting in Diabetic ketoacidosis(DKA)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

96 participants in 2 patient groups

Group 1:Usual Care
Active Comparator group
Treatment:
Procedure: Usual Care
Group 2: Permissive Care
Experimental group
Treatment:
Procedure: Permissive intrapartum glucose control

Trial contacts and locations

1

Loading...

Central trial contact

Ghamar Bitar, MD; Sunbola Ademola

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems